TB - Nursing Case Study

Pathophysiology

• Primary mechanism: Inhalation of Mycobacterium tuberculosis leads to the bacteria reaching the alveoli of the lungs, where they are phagocytosed by macrophages but not destroyed, allowing the bacteria to multiply within these immune cells.

• Secondary mechanism: The immune response forms granulomas to contain the infection, characterized by a core of infected macrophages surrounded by a layer of lymphocytes. This can lead to tissue necrosis and formation of caseating granulomas.

• Key complication: If the immune system fails to contain the bacteria, it can disseminate beyond the lungs, leading to miliary tuberculosis, which affects multiple organ systems and poses significant clinical challenges.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Latent TB infection diagnosed 5 years ago, hypertension

• Current medications: Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and weight loss

• Key symptoms: Night sweats, fever, chest pain, fatigue, decreased appetite

• Vital signs: Temperature 38.5°C, heart rate 110 bpm, respiratory rate 24 breaths/min, blood pressure 140/90 mmHg, oxygen saturation 92% on room air

Section 1

As the case progresses, the patient's status has evolved, indicating the emergence of new complications. Over the course of the next few days, the patient's cough becomes more productive, with occasional hemoptysis noted. His fever persists, and he continues to experience night sweats and significant weight loss, now totaling 7 kg in the past month. During a follow-up assessment, crackles and wheezing are auscultated in the upper lobes of the lungs, and the patient reports increasing difficulty in breathing, particularly during exertion. His oxygen saturation has decreased further to 89% on room air, prompting supplemental oxygen therapy.

Laboratory investigations reveal a marked leukocytosis with a white blood cell count of 15,000/mm³, elevated erythrocyte sedimentation rate (ESR) at 70 mm/hr, and a C-reactive protein (CRP) level of 65 mg/L, indicating a systemic inflammatory response. Sputum culture results return positive for Mycobacterium tuberculosis, confirming active pulmonary TB. A chest X-ray shows bilateral upper lobe infiltrates with cavitary lesions, suggesting extensive pulmonary involvement.

These findings suggest that the patient's latent TB has reactivated, and he is now facing complications related to active pulmonary tuberculosis. The presence of cavitary lesions and the drop in oxygen saturation indicate significant lung tissue damage, which poses an increased risk for further dissemination of the infection. The patient's clinical team must now prioritize the initiation of a multi-drug anti-tubercular regimen, adjust his oxygen therapy, and monitor for signs of miliary spread or additional organ involvement. The evolving nature of his condition underscores the need for vigilant assessment and timely intervention to manage potential complications effectively.

Section 2

Over the next few days, the patient's condition continues to evolve, highlighting new complications. Despite the initiation of a multi-drug anti-tubercular regimen, the patient develops new symptoms suggestive of extrapulmonary involvement. He begins experiencing persistent headaches, neck stiffness, and photophobia, raising concerns for potential tuberculous meningitis. Neurological examination reveals nuchal rigidity and a positive Brudzinski's sign, while his mental status remains intact but slightly lethargic. These signs prompt immediate further neurological evaluation.

A lumbar puncture is performed, yielding cerebrospinal fluid (CSF) analysis that shows elevated protein levels, low glucose concentration, and a pleocytosis with a lymphocytic predominance. These findings, in conjunction with positive CSF cultures for Mycobacterium tuberculosis, confirm the diagnosis of tuberculous meningitis. This new complication necessitates an adjustment in the treatment plan to include medications that penetrate the central nervous system effectively.

The patient's respiratory status remains tenuous, with oxygen saturation hovering around 91% on 2 liters of supplemental oxygen via nasal cannula. His respiratory rate has increased to 24 breaths per minute, reflecting increased work of breathing. The clinical team must now carefully balance managing his pulmonary symptoms with addressing the central nervous system involvement. This requires close monitoring of neurological status, careful titration of anti-tubercular medications to avoid toxicity, and continued respiratory support. The complexity of the patient's condition demands ongoing assessment and timely adjustments to the treatment protocol to prevent further deterioration and improve outcomes.

Section 3

Over the next 48 hours, the patient's condition presents a new set of challenges. Despite the initiation of treatment targeting the central nervous system, he develops signs of increased intracranial pressure, a known complication of tuberculous meningitis. The patient reports worsening headache, and the clinical team notes a decrease in his Glasgow Coma Scale (GCS) score to 13, indicating a decline in neurological function. His blood pressure reads 165/90 mmHg, with a pulse of 58 beats per minute, suggesting a Cushing's reflex, indicative of increased intracranial pressure. Additionally, his pupils are noted to be slightly unequal, with the right pupil sluggish to light, raising concerns for potential brainstem involvement.

Laboratory results reveal hyponatremia, with a sodium level of 127 mEq/L, which could be contributing to his altered mental status and may be indicative of syndrome of inappropriate antidiuretic hormone secretion (SIADH), a common complication in central nervous system infections. The team initiates careful fluid restriction and considers the use of hypertonic saline to correct the sodium imbalance while monitoring for potential fluid overload, given his pulmonary status. Imaging studies, including a CT scan of the brain, reveal mild ventricular enlargement but no evidence of acute hemorrhage or mass effect, supporting the hypothesis of raised intracranial pressure without overt hydrocephalus.

In response to these findings, the clinical team adjusts the patient's anti-tubercular regimen to optimize CNS penetration and adds dexamethasone to reduce inflammation and cerebral edema. Mannitol is considered to help manage the intracranial pressure, but its use is weighed against the risk of exacerbating his respiratory status. Concurrently, the patient's respiratory function is closely monitored, with adjustments made to his oxygen therapy to maintain adequate saturation levels. This careful balancing act underscores the complexity of managing a patient with multifaceted complications, requiring vigilant monitoring and timely therapeutic adjustments to prevent further deterioration and optimize patient outcomes.

Section 4

Over the next 24 hours, the patient's condition exhibits a marked response to the therapeutic interventions initiated by the clinical team. Following the adjustment of the anti-tubercular regimen and the administration of dexamethasone, there is a cautious improvement in his neurological status. His Glasgow Coma Scale (GCS) score increases to 14, and he reports a slight reduction in headache intensity. However, his blood pressure remains elevated at 160/88 mmHg, with a heart rate of 60 beats per minute, still suggestive of ongoing intracranial pressure concerns. The slight anisocoria persists, though both pupils now react briskly to light, indicating some relief in brainstem pressure.

Laboratory results show a gradual correction of hyponatremia, with sodium levels rising to 130 mEq/L, suggesting an effective response to fluid restriction and the cautious use of hypertonic saline. Despite these positive trends, the patient's respiratory status warrants attention. He exhibits mild tachypnea, with a respiratory rate of 22 breaths per minute, and occasional desaturation episodes, with oxygen saturation fluctuating between 90-92% on supplemental oxygen via nasal cannula. This respiratory pattern prompts a reevaluation of fluid management strategies to prevent pulmonary complications, balancing between sodium correction and fluid overload.

While the interventions appear to stabilize the patient's CNS and metabolic parameters, the team remains vigilant for signs of new complications. The potential for aspiration pneumonia, given the altered mental status and respiratory changes, necessitates preventive measures such as ensuring an elevated head-of-bed position and considering swallowing assessments. The clinical picture underscores the need for continuous monitoring and proactive adjustments in the management plan, emphasizing the importance of addressing interconnected systems to optimize recovery and prevent further complications.

Section 5

The patient continues to be closely monitored, and over the next several hours, there is a notable change in his respiratory status. Despite previous stabilization efforts, he begins to exhibit increased respiratory distress. His respiratory rate rises to 28 breaths per minute, and he becomes more tachypneic. Oxygen saturation dips further, ranging between 88-90% even with the nasal cannula delivering 3 liters per minute of oxygen. Auscultation of the lungs reveals decreased breath sounds in the right lower lobe, accompanied by coarse crackles. This clinical presentation raises the suspicion of a developing pulmonary complication, possibly aspiration pneumonia given the patient's recent neurological compromise and altered swallowing function.

In response to these findings, the clinical team orders a chest X-ray, which reveals right lower lobe infiltrates consistent with aspiration pneumonia. Laboratory tests show an elevated white blood cell count of 14,000/mm³, indicating a possible infectious process. Given these new diagnostic results, the team initiates empirical antibiotic therapy to target potential pathogens commonly associated with aspiration pneumonia. The fluid management strategy is also adjusted to address the potential for pulmonary edema, balancing the need for adequate hydration with the risk of fluid overload.

This change in the patient's status necessitates a reevaluation of the current care plan. The team prioritizes optimizing respiratory support, including considering non-invasive ventilation options if the patient's oxygenation does not improve. The need for collaborative care becomes evident, with input from respiratory therapists, speech therapists for swallowing assessment, and infectious disease specialists to refine antibiotic therapy. The interconnectedness of the patient's systems highlights the importance of a comprehensive approach to prevent further deterioration and support recovery. The next phase of the patient's journey will focus on stabilizing respiratory function while continuing to monitor for other potential complications.